@_EarningsRadar

My favorite company is reporting tomorrow $AMD

First 100 people to join #earningsradar via our waitlist get one free month of our plus features after launch

$PLTR almost 145!!!

$VRTX beneath the print: revenue growth (CF uptake + CASGEVY/JOURNAVX diversification) outpaced a jump in combined R&D/SG&A spend tied to the JOURNAVX launch and renal build-out. Tax rate rose to 21.1% from 19.4% YoY, yet non-GAAP net income still grew.

VERTEX PHARMACEUTICALS JUST REPORTED EARNINGS *REVENUE: $3.33B vs $3.30B est (BEAT ✅) *ADJ EPS: $4.94 vs $4.82 est (BEAT ✅) *FY REVENUE GUIDANCE: raised to $13.1B-$13.2B *JOURNAVX REVENUE: $50M (+71% QoQ) $VRTX